Ten Washington state health organizations recently received grants of up to $15,000 from Fred Hutch Cancer Center’s Community ...

At first glance, art and science might seem like opposite worlds — one driven by imagination and emotion, the other by data ...

Dr. Folashade Otegbeye, facility director of the Therapeutic Products Program at Fred Hutch, works to rapidly translate what ...

In 2024, Obliteride raised more than $9 million for research at Fred Hutch, contributing to more than $58 million raised since 2013. These funds have fueled urgently needed advances in cancer ...

A study from Fred Hutch Cancer Center finds that some cancer patients' antibodies can boost their response to immunotherapy treatment.

A Fred Hutch Cancer Center outpatient complex serving more than 60,000 adult patients per year will be renamed the Sloan Clinic in recognition of Stuart and Molly Sloan, who have increased their total ...

Patient provider profile for Dr. Michael Schweizer, medical oncologist at Fred Hutchinson Cancer Center.

Blood clots can be a common – and even deadly – side effect of both cancer and its treatment. Fred Hutch's Dr. Gary Lyman, an expert in blood clots (also known as thrombi) is helping set national ...

Far too many cancer patients face barriers to participating in clinical trials due to overly restrictive trial criteria. Here's how Fred Hutch researchers are changing that..

Worried about health effects from the U.S.’s increasingly smoky summers? One day, not far in the future, you may be able to pop a few pills that will help your cells pinpoint and extract the worst of ...